Paid Clinical Trials in Flower Mound, TX
As of July 2026, 21 paid clinical trials are recruiting in Flower Mound, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Flower Mound offers studies at sites including Neurology Rare Disease Center for conditions such as Breast Cancer, Breast Neoplasms, Duchenne Muscular Dystrophy, Acinar Cell Carcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Flower Mound
Trials by drug in Flower Mound
Filter results
21 clinical trials
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort
Two Dose Levels of Privigen in Pediatric CIDP
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Top Research Study Locations in Flower Mound
Researchers run research studies in Flower Mound, TX at 7 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Neurology Rare Disease Center | Duchenne Muscular Dystrophy, Anti-myostatin, Muscular Atrophy, Spinal | 6 |
| Texas Oncology - Northeast Texas | Acinar Cell Carcinoma, Advanced Cancer, Advanced Non-Small Cell Lung Cancer | 6 |
| Texas Oncology-Northeast Texas | Breast Cancer, Breast Neoplasms, Non-Small Cell Lung Cancer Metastatic | 3 |
| Texas Oncology - Flower Mound | Breast Cancer, HR+/HER2-negative Breast Cancer | 2 |
| Neurology and Neuromuscular Care Center-Neurology Rare Disease Center | Primary Mitochondrial Disease | 1 |
| North Pointe Psychiatry | Irritability Associated With Autism Spectrum Disorder | 1 |
| North Pointe Psychiatry - Flower Mound | Agitation, Alzheimer Disease | 1 |
Active & Upcoming Studies in Flower Mound (2026)
Recruiting trials in Flower Mound grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (9 active studies)
- Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer · Phase 3 · Pfizer
- A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC) · Phase 3 · Pfizer
Neurology & pain (1 active study)
Pediatric (1 active study)
- Two Dose Levels of Privigen in Pediatric CIDP · Phase 4 · CSL Behring
Common conditions studied in Flower Mound
- Breast Cancer (3 active studies)
- Breast Neoplasms (3 active studies)
- Duchenne Muscular Dystrophy (2 active studies)
- Acinar Cell Carcinoma (1 active study)
- Advanced Cancer (1 active study)
- Advanced Non-Small Cell Lung Cancer (1 active study)
Leading research sponsors in Flower Mound
- Pfizer
- Merck Sharp & Dohme LLC
- Agendia
- Artios Pharma Ltd
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Flower Mound?
There are approximately 21 recruiting clinical trials in Flower Mound, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Flower Mound pay participants?
Most recruiting trials in Flower Mound compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Flower Mound?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Flower Mound?
The most common conditions under active study in Flower Mound include Breast Cancer (3), Breast Neoplasms (3), Duchenne Muscular Dystrophy (2), Acinar Cell Carcinoma (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Flower Mound?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Flower Mound on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Flower Mound?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Flower Mound?
Recruiting research sites in Flower Mound include Neurology Rare Disease Center, Texas Oncology - Northeast Texas, Texas Oncology-Northeast Texas, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Flower Mound right now?
The largest active categories in Flower Mound are Cancer & tumors (9), Neurology & pain (1), Pediatric (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.